JAMES ANDERSON: Open Payments
NPI 1427348929 · WHEAT RIDGE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,873 in 170 payments from 16 companies in 2025. Trend: 2023 $4,795 · 2024 $3,912 · 2025 $4,873
Food & beverage: $4,873
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $728 |
| E.R. Squibb & Sons, L.L.C. | 18 | $727 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $621 |
| Axsome Therapeutics, Inc. | 13 | $562 |
| Lundbeck LLC | 28 | $475 |
| Teva Pharmaceuticals USA, Inc. | 10 | $352 |
| Alkermes, Inc. | 12 | $302 |
| Otsuka America Pharmaceutical, Inc. | 9 | $280 |
| Tris Pharma Inc | 5 | $188 |
| Supernus Pharmaceuticals, Inc. | 6 | $173 |
Products named: REXULTI, VRAYLAR, COBENFY, CAPLYTA, Auvelity, UZEDY, Dyanavel XR, ARISTADA.
Industry payments across CO — which companies pay providers there.
